In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.

or AFib, in people who had electronic devices implanted in their chests to help monitor and regulate their heartbeats, the ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

PRNewswire New York [US] 13 Fourth Frontier a medical technology company based out of New York and Bangalore announced the ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11 percent, a new study shows.

Wearable AF monitoring devices are extensively used ... and maintaining normal sinus rhythm. Atrial Fibrillation (AF) is the most common sustained heart arrhythmia in adults, affecting ...

allow for continuous monitoring of heart rhythms. These innovations improve patient outcomes by enabling timely interventions and reducing hospitalizations, thereby increasing demand for these devices ...